Review Article

Biologicals and biosimilars: a review of the science and its implications

Published in: Volume 1 / Year 2012 / Issue 1
Author(s):
Page: 13-6

Abstract: Biopharmaceuticals are medicines whose active drug substance is made by living cells. Copies of these drugs, called biosimilars, are not identical to their reference drug and therefore specific regulatory… Read More »

A review of generic medicine pricing in Europe

Published in: Volume 1 / Year 2012 / Issue 1
Author(s):
Page: 08-12

Introduction: Switching from originator products to generic equivalents is a key method used by governments to reduce costs and keep their healthcare systems sustainable. The aim of this article is… Read More »

Pharmaceutical Data Integrity: issues, challenges and proposed solutions for manufacturers and inspectors

Published in: Volume 9 / Year 2020 / Issue 4
Author(s): , , ,

Author byline as per print journal: Adjunct Associate Professor Sia Chong Hock1, BSc (Pharm), MSc; Vernon Tay1, BSc (Pharm) (Hons); Vimal Sachdeva2, MSc; Associate Professor Chan Lai Wah1, BSc (Pharm)… Read More »

An overview of the current status and future perspectives of the biosimilars and follow-on biologics in Iran

Author(s): ,

Background The advent of biosimilars and follow-on biologics in Iran has provided various treatment options for several severe and chronic diseases. The goal of the present study was to provide… Read More »

Continuous manufacturing versus batch manufacturing: benefits, opportunities and challenges for manufacturers and regulators

Author(s): , ,

Author byline as per print journal: Adjunct Associate Professor Sia Chong Hock, BSc (Pharm), MSc; Teh Kee Siang, Associate Professor Chan Lai Wah, BSc (Pharm) (Hons), PhD Abstract: Continuous manufacturing… Read More »

Page 5 of 5 « Previous1 2 3 4 5
Go Back Print